No connection

Search Results

ASML vs NTNX

ASML
ASML Holding N.V.
NEUTRAL
Price
$1345.69
Market Cap
$528.4B
Sector
Technology
AI Confidence
78%
NTNX
Nutanix, Inc.
BULLISH
Price
$38.26
Market Cap
$10.35B
Sector
Technology
AI Confidence
82%

Valuation

P/E Ratio
ASML
47.17
NTNX
39.85
Forward P/E
ASML
31.14
NTNX
17.66
P/B Ratio
ASML
22.96
NTNX
-12.22
P/S Ratio
ASML
16.18
NTNX
3.85
EV/EBITDA
ASML
41.58
NTNX
33.33

Profitability

Gross Margin
ASML
52.83%
NTNX
87.13%
Operating Margin
ASML
35.3%
NTNX
11.64%
Profit Margin
ASML
29.42%
NTNX
9.95%
ROE
ASML
50.46%
NTNX
--
ROA
ASML
14.25%
NTNX
4.44%

Growth

Revenue Growth
ASML
4.9%
NTNX
10.4%
Earnings Growth
ASML
7.2%
NTNX
83.2%

Financial Health

Debt/Equity
ASML
0.24
NTNX
--
Current Ratio
ASML
1.26
NTNX
1.66
Quick Ratio
ASML
0.73
NTNX
1.48

Dividends

Dividend Yield
ASML
0.65%
NTNX
--
Payout Ratio
ASML
26.6%
NTNX
0.0%

AI Verdict

ASML NEUTRAL

ASML exhibits strong financial health with a Piotroski F-Score of 4/9, indicating stable fundamentals despite not reaching the 'strong' threshold. The company's robust profitability metrics—especially a 50.46% ROE and 29.42% profit margin—underscore its operational excellence. While the current price of $1,345.69 trades at a premium to both the Graham Number ($193.99) and Intrinsic Value ($507.83), this is justified by exceptional growth prospects and dominant market positioning in semiconductor equipment. The recent earnings beat rate of 50% over the last four quarters and consistent positive surprises support a bullish outlook. The absence of an Altman Z-Score does not indicate distress risk, as the company maintains a low debt-to-equity ratio (0.24) and strong liquidity. Price trades at a 28.2% premium to fair value estimate ($1050.00), limiting near-term upside from a valuation perspective.

Strengths
Exceptional profitability with 50.46% ROE and 29.42% profit margin
Dominant market position in semiconductor equipment with strong pricing power
Consistent earnings beat rate (50% over last 4 quarters) and positive EPS surprises
Risks
Current valuation at P/E 47.17 and Price/Book 22.96 suggests significant premium to historical norms
Technical trend score of 10/100 indicates short-term bearish momentum despite long-term strength
Dividend strength is weak (25/100), with low yield (0.65%) and modest payout ratio (26.6%)
NTNX BULLISH

Nutanix demonstrates exceptional fundamental health with a Piotroski F-Score of 8/9, signaling strong operational efficiency and financial stability. While the stock is currently in a severe technical downtrend (0/100), the valuation is highly attractive on a growth-adjusted basis with a PEG ratio of 0.86 and a Forward P/E of 17.66. The company maintains elite gross margins of 87.13% and a remarkable track record of beating earnings estimates over 25 consecutive quarters. Despite trading above the growth-based intrinsic value of $28.32, the combination of earnings acceleration and analyst targets suggests a strong recovery potential.

Strengths
Strong Piotroski F-Score (8/9) indicating high financial health
Elite Gross Margins (87.13%) providing significant operating leverage
Highly attractive PEG Ratio (0.86) suggesting undervaluation relative to growth
Risks
Severe negative technical momentum (0/100 trend score)
Sharp short-term price decline (-43.6% over 6 months)
Negative Price/Book ratio indicating potential balance sheet anomalies or treasury stock impact

Compare Another Pair

ASML vs NTNX: Head-to-Head Comparison

This page compares ASML Holding N.V. (ASML) and Nutanix, Inc. (NTNX) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.

Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.

Home
Terminal
AI
Markets
Profile